AstraZeneca and Targacept released results of the second of four phase-3 clinical trials that investigated the efficacy and tolerability of a drug that could serve as an adjunct therapy to major depressive disorder patients that had an inadequate response to initial antidepressant therapies.
One-in-eight Americans didn't fill prescriptions last year because they couldn't afford to, but despite difficulties with the economy, that proportion remained level, according to a new study conducted by the Center for Studying Health System Change and funded by the Robert Wood Johnson Foundation.
According to an article in the November/December issue of the journal Medical-Surgical Nursing, rates of HIV/AIDS, herpes, syphilis, human papilloma virus and other STDs are climbing steadily across men and women older than 50 years.
The American Diabetes Association on Thursday announced that Walgreens will become a national strategic partner, and that the national drug store chain again is working with the association as one of its partner charities within "Walgreens Way to Well Commitment" — a four-year, $100 million health-and-wellness initiative.
Approximately 5.3% of high school seniors abused over-the-counter cough-cold medicines in the past month, according to the latest "Monitoring the Future" survey released Wednesday by the National Institute on Drug Abuse.
The Centers for Disease Control and Prevention and the Consumer Healthcare Products Association Educational Foundation on Tuesday launched the Up and Away and Out of Sight educational program to help educate parents on the importance of keeping their medicines in a safe place from children.
Walgreens and Access Community Health Network of Chicago on Tuesday teamed up in an effort to protect more people in Chicago’s medically underserved communities from the flu this season, through a new program in which Walgreens will provide more than 10,000 free flu shot vouchers for eligible Access patients.
The Federal Trade Commission has voted to approve Valeant's acquisitions of Dermik, a unit of French drug maker Sanofi that makes drugs for skin conditions, and Ortho Dermatologics, a division of Johnson & Johnson that also makes skin drugs.
The Department of Health and Human Services on Monday announced that the first U.S. facility to use a faster and more flexible technology to make influenza vaccine was dedicated as part of an initiative that could provide vaccine supplies sooner in an influenza pandemic.